Glencore PLC (GLN)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 11,849.00 |
|---|---|
| 52-week range | 7,614.00 – 13,750.00 |
| Return, 1 month / 3 months | +2.0% / +2.1% |
| Return, 1 year / 3 years | +54.1% / +27.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 39 |
| Volatility (1 year) | 31.9% |
| Worst drawdown (1 year) | -18.8% |
| Average daily value traded | 42,549.96M ZAC |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Glencore is a commodities company that mines and trades raw materials. It produces metals and minerals such as copper, cobalt, zinc and nickel, and it trades these along with energy products including oil and coal. Its customers are industrial firms, smelters, refiners and other buyers of commodities around the world. The company is based in Switzerland and operates mines, processing plants and trading offices in many countries.
On this site Glencore PLC appears as a stock on the Johannesburg Exchange (South Africa), code GLN, with prices in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Glencore PLC (GLN) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 11,849.00 on 22 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 44 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 54.1% and over the last three months it rose 2.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 0.9% | ||
| From 52-week high | -13.0% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.1% | ||
| 6-month return | -1.6% | ||
| 12-month return, skipping the last month | 51.1% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.8% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 42,549.96M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −5.5% |
|---|---|
| 1 month | +2.0% |
| 3 months | +2.1% |
| 6 months | −1.6% |
| 1 year | +54.1% |
| 3 years | +27.7% |
| 5 years | +97.6% |
Signals
| 50-day / 200-day average | 12,536.94 / 11,743.19 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 355.68 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Aug 2026 | ZAC 280.0767 |
| 6 May 2026 | ZAC 140.0384 |
| 27 Aug 2025 | ZAC 82.3755 |
| 29 Apr 2025 | ZAC 82.3755 |
| 28 Aug 2024 | ZAC 107.0881 |
| 30 Apr 2024 | ZAC 107.0881 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.